BCL2 and cancer: Since cells of different origins can vary in their dependence on antiapoptotic proteins, precise knowledge of the Bcl-2 interactome could help to predict the response of tumor cells to BH3-mimetics or to design new compounds to activate the intrinsic pathway of apoptosis in cancer cells.